$GS

UBS maintains Goldman Sachs Group at Neutral, lowers price target to $1000 from $1010

UBS kept its Neutral rating on Goldman Sachs (GS) but reduced its price target to $1000 from $1010, a 1.0% cut. The new target suggests an 11.3% upside from the Nov 2 close of $898.72. Recent analyst price targets for GS range from $950 to $1100.

Original reporting
Published Nov 2, 2026, 10:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 10:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UBS maintains Goldman Sachs Group at Neutral, lowers price target to $1000 from $1010 — source image
Decision brief

The 30-second read

$GSNeutralLow
01

Why it matters

A modest reduction in the price target can influence short-term positioning, but without new earnings, guidance, or event risk it is unlikely to drive a major repricing alone.

02

Market read

Traders may adjust expectations for GS valuation, but the unchanged rating and lack of new fundamentals keep the signal weak.

03

What to watch

The article notes a wide range of recent targets ($950 to $1100), suggesting consensus dispersion that can mute the effect of any one bank’s change.

Relevance 4/10Novelty 3/10Timing: after-hours/overnight analyst note update, no scheduled catalyst

Background

The piece is an analyst update from UBS summarizing its stance on Goldman Sachs Group.

Company-level read

Ticker impact

$GSNeutralMedium confidence
Context

UBS maintained Goldman Sachs Group at Neutral and cut its price target to $1000 from $1010, signaling a modest valuation reset.

Expected impact

Likely mild downward pressure as the market digests a lower UBS valuation, though the unchanged Neutral rating limits downside momentum.

Evidence & confidence

This is a single-bank price-target cut without a rating change or new fundamental catalyst in the article, so impact should be limited.

Market effects

Adds incremental caution to large-cap investment banking sentiment, but no sector-wide catalyst is provided.

Primarily affects US financials sentiment; no cross-region macro or policy trigger is mentioned.

Limited global spillover since the news is a single-bank target adjustment for one US-listed firm.

Counterpoint

Because the rating stays Neutral, the target cut may be more about valuation math than a deterioration in fundamentals, so traders may fade the impact.

Key entities

  • Goldman Sachs Group

    UBS maintained a Neutral rating and lowered its price target to $1000 from $1010.

Related articles

$GSMedAI 9/10

Goldman Sachs in talks to acquire controlling stake in TMAP Mobility

Goldman Sachs is in talks to acquire a 60-70% stake in TMAP Mobility, operator of Korea's leading navigation service TMAP, from SK Square, its largest shareholder. SK Square holds 63.23% and may retain part of its stake. The deal, valued at 700-800 billion won ($522.6-597.2 million), could close by year-end. SK Square is restructuring, focusing on AI and semiconductors.

$GSMedAI 8/10

In Anthropic’s IPO, Goldman and Morgan Stanley slug it out for top bank

Anthropic named Goldman Sachs and Morgan Stanley as lead underwriters for its upcoming IPO, with Goldman as the 'lead left' bank and Morgan Stanley as the stabilization agent. Both banks previously held similar roles in SpaceX's IPO, earning around $100 million each. Anthropic's IPO is expected to be the largest ever. Goldman and Morgan Stanley have also been involved in other major tech financing deals, benefiting from the AI boom.

$GSMed

Form 424B2 GOLDMAN SACHS GROUP INC

Goldman Sachs Group Inc. is offering autocallable buffered basket-linked notes due 2028, guaranteed by the company. The notes' payout is based on the performance of a basket of 7 stocks, with an initial estimated value of $900-$930 per $1,000 face amount. The notes may be automatically called in 2027 if the basket performs well, with a minimum payout of $1,184.5 per $1,000 note.

$GSMed

Goldman Sachs Drives Major AI Financing Deals Amid $210 Billion

Goldman Sachs (GS) participated in three major AI financing deals totaling $210B, including Meta's $95B stock issuance and SpaceX's $40B chip financing. The deals may generate substantial fees. GS offers a 2.1% dividend yield and has a GF Score of 87, indicating strong performance but weaker financial strength. Insider activity shows mixed trends.